Lifestyle
- Increase physical activity
- Quit smoking
- Maintain a healthy weight
High-Density Lipoprotein · HDL-C · HDL
HDL-C quantifies the concentration of high-density lipoprotein cholesterol in the blood, reflecting the body's ability to transport cholesterol from tissues to the liver.
Reference ranges can vary by sex and age. Fasting is recommended for accurate assessment.
High-Density Lipoprotein Cholesterol (HDL-C) is a key component of the lipid profile, often referred to as 'good' cholesterol. It is a complex of lipids and proteins that transports cholesterol from the arteries to the liver for excretion or re-utilization. Clinically, HDL-C is significant as it is inversely related to the risk of atherosclerotic cardiovascular disease (ASCVD), which includes coronary artery disease, peripheral vascular disease, and cerebrovascular disease. Low levels of HDL-C are associated with increased risk of these conditions, while high levels are generally protective. In the context of athletic performance and biohacking, maintaining optimal HDL-C levels is considered beneficial for cardiovascular health and longevity. However, very high levels may also pose risks, particularly in the presence of genetic factors. Caveats in measuring HDL-C include potential confounders such as acute illness, medications, and genetic disorders. Fasting is typically required for accurate measurement, and levels can vary based on time of day and other physiological factors.
Klinische Bedeutung
Elevated HDL-C levels are generally protective against atherosclerotic cardiovascular disease, while reduced levels are associated with increased risk. Extremely high or low levels may indicate underlying genetic disorders.
Progressively rising HDL-C values suggest improved cardiovascular protection. Re-test annually unless clinically indicated.
Progressively falling HDL-C values may indicate increased cardiovascular risk and warrant lifestyle or therapeutic intervention.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any supplements, especially if you have underlying health conditions.
Testing Frequency
Annually for healthy adults, more frequently if managing cardiovascular risk.
Current research suggests that the optimal reference ranges and targets for HDL-C levels in relation to various diseases, including cancer and osteoporosis, remain debated, particularly regarding the impact of confounding factors like inflammation and genetics. Researchers have not yet established the molecular mechanisms linking HDL-C to tumor progression and the specific role of HDL-C in age-related ocular diseases. Additionally, clinical questions regarding the implications of both low and high HDL-C levels on long-term health outcomes remain unanswered.
685
Total Citations
7
Human/RCT
3.8
Avg. Influence
2021
Latest
Researchers found that the ratio of triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) may serve as a novel biomarker for predicting the risk of metabolic syndrome and cardiovascular disease. The study highlighted the importance of both triglycerides and HDL-C levels in the formation of atherosclerotic plaques. This review discusses current scientific data linking TG/HDL-C ratio with various cardiovascular diseases.
Researchers observed a positive relationship between high-density lipoprotein cholesterol (HDL-C) levels and lumbar bone mineral density (BMD) in U.S. adults aged 20-59. The study found that this association varied by sex and race, with a U-shaped curve identified for men and whites. HDL-C measurement may serve as a useful biomarker for early osteoporosis detection.
Researchers observed that low levels of high-density lipoprotein cholesterol (HDL-C) are significant risk factors for cardiovascular disease (CVD). The study emphasizes the importance of genetic analysis in diagnosing HDL deficiency and its associated health risks.
This review analyzed the role of high-density lipoprotein cholesterol (HDL-C) in colorectal cancer (CRC). Researchers found that HDL-C levels decrease in CRC patients, and emphasized the need for further studies on HDL functionality and its potential as a biomarker in CRC.
This study investigated hypertriglyceridemia in obese children and adolescents, focusing on the TG/HDL-C ratio as a marker of cardiometabolic risk. Researchers found that elevated TG levels are common in this population and recommended lifestyle modifications to manage triglyceride levels.
This review focused on the relationship between high-density lipoprotein (HDL) and cancer, particularly in endocrine carcinomas. Researchers observed that HDL-C levels may inversely correlate with cancer risk and suggested potential therapeutic applications of synthetic HDL in cancer treatment.
Researchers reviewed the role of high-density lipoprotein cholesterol (HDL-C) in age-related ocular diseases, including macular degeneration and cataracts. The review highlights the limited understanding of HDL-C's specific contributions to these diseases. Epidemiological and genetic evidence is discussed to explore potential links between HDL-C and ocular health.
Researchers observed a potential negative association between high-density lipoprotein cholesterol (HDL-C) levels and tumor incidence, suggesting that HDL-C may play a role in cancer prognosis. The review discusses the impact of HDL-C on cancer development and progression, although molecular mechanisms remain unclear. This study emphasizes the need for further research on HDL-C as a biomarker for tumors.
This review examined recombinant high-density lipoprotein formulations as potential therapies for cardiovascular disease. Researchers noted that while these therapies show promise, further clinical trials are necessary to evaluate their effectiveness in reducing cardiovascular events.
Researchers examined the relationship between the platelet to high-density lipoprotein cholesterol (PHR) ratio and bone mineral density (BMD). They found a nonlinear, inverted U-shaped relationship, indicating that optimal PHR levels may be important for bone health. The study suggests that changes in PHR could reflect inflammatory states affecting bone resorption.
Research publications about HDL-Cholesterin over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer